HRP20030194A2 - Use of triazinetrione sulfones for combating coccidiosis - Google Patents

Use of triazinetrione sulfones for combating coccidiosis Download PDF

Info

Publication number
HRP20030194A2
HRP20030194A2 HR20030194A HRP20030194A HRP20030194A2 HR P20030194 A2 HRP20030194 A2 HR P20030194A2 HR 20030194 A HR20030194 A HR 20030194A HR P20030194 A HRP20030194 A HR P20030194A HR P20030194 A2 HRP20030194 A2 HR P20030194A2
Authority
HR
Croatia
Prior art keywords
concentration
compounds
formula
agent
substances
Prior art date
Application number
HR20030194A
Other languages
English (en)
Croatian (hr)
Inventor
Greif Gisela
Heep Iris
Mundt Hans-Christian
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of HRP20030194A2 publication Critical patent/HRP20030194A2/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/30Only oxygen atoms
    • C07D251/34Cyanuric or isocyanuric esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20030194A 2000-08-17 2003-03-14 Use of triazinetrione sulfones for combating coccidiosis HRP20030194A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040174A DE10040174A1 (de) 2000-08-17 2000-08-17 Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
PCT/EP2001/009060 WO2002014288A1 (de) 2000-08-17 2001-08-06 Verwendung von triazintrion-sulfonen zur bekämpfung von coccidiosen

Publications (1)

Publication Number Publication Date
HRP20030194A2 true HRP20030194A2 (en) 2005-10-31

Family

ID=7652719

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030194A HRP20030194A2 (en) 2000-08-17 2003-03-14 Use of triazinetrione sulfones for combating coccidiosis

Country Status (23)

Country Link
US (1) US7915257B2 (ja)
EP (1) EP1311491A1 (ja)
JP (1) JP2004506624A (ja)
KR (1) KR100803078B1 (ja)
CN (3) CN1469868A (ja)
AR (1) AR030378A1 (ja)
AU (2) AU7852201A (ja)
BR (1) BR0113268A (ja)
CA (1) CA2419471C (ja)
CZ (1) CZ300020B6 (ja)
DE (1) DE10040174A1 (ja)
HR (1) HRP20030194A2 (ja)
HU (1) HUP0303701A3 (ja)
MX (1) MXPA03001429A (ja)
MY (1) MY136518A (ja)
NO (1) NO20030585D0 (ja)
NZ (1) NZ524200A (ja)
PL (1) PL359709A1 (ja)
SK (1) SK1652003A3 (ja)
TW (1) TW200819431A (ja)
WO (1) WO2002014288A1 (ja)
YU (1) YU11703A (ja)
ZA (1) ZA200301225B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
SI22751A (sl) * 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
EP2740470A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP2740469A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
CN102973497A (zh) * 2012-12-13 2013-03-20 江苏恒丰强生物技术有限公司 一种托曲珠利溶液及其制备方法
BR112020017341A2 (pt) 2018-02-26 2020-12-15 AlzeCure Pharma AB Derivados de triazina para o tratamento de doenças relacionadas a neurotrofinas
EP3578181A1 (en) * 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413722C3 (de) 1974-03-21 1982-04-08 Bayer Ag, 5090 Leverkusen Neue 1-(4-Phenoxy-phenyl)-1,3,5-triazin-Derivate, ein Verfahren zu ihrer Herstellung sowie ihre Anwendung als Arzneimittel
DE2414612A1 (de) 1974-03-26 1975-10-16 Bayer Ag 1-aryluracile, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2532363A1 (de) 1975-07-19 1977-02-03 Bayer Ag Substituierte 2-phenyl-1,2,4- triazin-3,5(2h,4h)-dione, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
US4255231A (en) * 1979-06-13 1981-03-10 Congoleum Corporation Carpet etching
DE3314739A1 (de) * 1983-04-23 1984-10-25 Bayer Ag, 5090 Leverkusen 1-(4-(4-(fluoralkylmethylthio- oder -sulfinyl- oder -sulfonyl-)phenoxy) phenyl)-1,3,5-triazin-2,4,6(1h,3h,5h)-trione, verfahren zu ihrer herstellung und ihre verwendung als coccidiosemittel
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
US4808404A (en) * 1988-01-11 1989-02-28 A. H. Robins Company, Inc. Live vaccine for coccidiosis utilizing coccidial sporozoites
DE19824483A1 (de) 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
MXPA01003542A (es) * 1998-10-08 2002-09-18 New Ace Res Company Composiciones y metodos nuevos para la prevencion y tratamiento de enfermedad causada por protozoarios.
BR9916417A (pt) * 1998-12-22 2001-11-06 Bayer Ag Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Also Published As

Publication number Publication date
HUP0303701A3 (en) 2006-01-30
KR20030017659A (ko) 2003-03-03
US20040013699A1 (en) 2004-01-22
US7915257B2 (en) 2011-03-29
HUP0303701A2 (hu) 2004-03-29
NZ524200A (en) 2005-02-25
MXPA03001429A (es) 2004-05-04
PL359709A1 (en) 2004-09-06
AU2001278522B9 (en) 2002-02-25
MY136518A (en) 2008-10-31
BR0113268A (pt) 2003-07-08
TW200819431A (en) 2008-05-01
NO20030585L (no) 2003-02-06
CN1853635A (zh) 2006-11-01
ZA200301225B (en) 2004-02-16
NO20030585D0 (no) 2003-02-06
YU11703A (sh) 2006-01-16
WO2002014288A1 (de) 2002-02-21
CZ300020B6 (cs) 2009-01-14
EP1311491A1 (de) 2003-05-21
JP2004506624A (ja) 2004-03-04
KR100803078B1 (ko) 2008-02-18
SK1652003A3 (en) 2004-02-03
AU7852201A (en) 2002-02-25
DE10040174A1 (de) 2002-02-28
CA2419471C (en) 2009-10-13
CA2419471A1 (en) 2003-02-14
CN1469868A (zh) 2004-01-21
CN101361743A (zh) 2009-02-11
AR030378A1 (es) 2003-08-20
AU2001278522B2 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
KR101489763B1 (ko) 콕시디아 감염을 구제하기 위한 트리아진의 경피 적용
HRP20030194A2 (en) Use of triazinetrione sulfones for combating coccidiosis
JPH11505854A (ja) 寄生性原生動物に対する使用のための薬剤
US20030181451A1 (en) Use of triazinetrione sulfoxides for controlling coccidioses
EP1789038A1 (de) Kombination von substituierten benzimidazolen und triazinderivaten mit antiparasitärer wirkung
CA2222517C (en) Agents for use against parasitic protozoa
CA2250507A1 (en) Use of substituted aryl imidazoles
DE102009038950A1 (de) Neue antiparasitäre Kombination von Wirkstoffen
MXPA97009187A (en) Agents against parasi protocols

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: BAYER ANIMAL HEALTH GMBH, DE

ODRP Renewal fee for the maintenance of a patent

Payment date: 20090803

Year of fee payment: 9

ODBI Application refused